Notably, as the main site for α1AT biosynthesis is the liver, the accumulation of mutated α1AT in the ER of hepatocytes is a risk factor for the development of childhood liver disease (gain-of-toxic function phenotype) [78]. This evidence concerns the gene SERPINA1 and liver disorder.